| Stage | MIR | % of rev | RMBS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $278M | 100.00% | $218M | 100.00% | MIR ×1.27 |
| Gross profit | $132M | 47.34% | $171M | 78.30% | RMBS +31.0pp |
| Operating income | $17M | 6.19% | $84M | 38.32% | RMBS +32.1pp |
| Pre-tax income | $11M | 3.92% | $91M | 41.47% | RMBS +37.6pp |
| Net income | $8M | 2.81% | $75M | 34.16% | RMBS +31.4pp |
| Stage | MIR | RMBS | Gap · A − B |
|---|---|---|---|
| Revenue | $278M100.00% | $218M100.00% | MIR ×1.27 |
| Gross profit | 47.34%$132M | 78.30%$171M | RMBS +31.0pp |
| Operating income | 6.19%$17M | 38.32%$84M | RMBS +32.1pp |
| Pre-tax income | 3.92%$11M | 41.47%$91M | RMBS +37.6pp |
| Net income |
| 2.81%$8M |
| 34.16%$75M |
| RMBS +31.4pp |
None
No disclosed counterparties: MIR.